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Abstract
Background: N-Acetylserotonin O-methyltransferase (ASMT) is an enzyme which by
converting nor-melatonin to melatonin catalyzes the final reaction in melatonin
biosynthesis in tryptophan metabolism pathway. High Expression of ASMT gene is
evident in PPTs. The presence of abnormally high levels of ASMT in pineal gland could
serve as an indication of the existence of pineal parenchymal tumors (PPTs) in the brain
(J Neuropathol Exp Neurol 65: 675–684, 2006). Different levels of melatonin are used as
a trait marker for prescribing the mood disorders e.g. Seasonal affective disorder, bipolar
disorder, or major depressive disorder. In addition, melatonin levels can also be used to
calculate the severity of a patient’s illness at a given point in time.
Methods: Seventy three melatoninergic inhibitors were docked with acetylserotonin-O-
methyltransferase in order to identify the potent inhibitor against the enzyme. The
chemical nature of the protein and ligands greatly influence the performance of
docking routines. Keeping this fact in view, critical evaluation of the performance of
four different commonly used docking routines: AutoDock/Vina, GOLD, FlexX and FRED
were performed. An evaluation criterion was based on the binding affinities/docking
scores and experimental bioactivities.
Results and conclusion: Results indicated that both hydrogen bonding and
hydrophobic interactions contributed significantly for its ligand binding and the
compound selected as potent inhibitor is having minimum binding affinity, maximum
GoldScore and minimum FlexX energy. The correlation value of r
2=0. 66 may be useful
in the selection of correct docked complexes based on the energy without having prior
knowledge of the active site. This may lead to further understanding of structures, their
reliability and Biomolecular activity especially in connection with bipolar disorders.
Keywords: Acetylserotonin-O-methyltransferase, Bipolar disorders, Pineal parenchymal
tumors, Melatoninergic inhibitors, Molecular docking, Binding affinities
Background
N-Acetylserotonin-O-methyltransferase (ASMT) is an enzyme which by converting
nor-melatonin to melatonin catalyzes the final reaction in melatonin biosynthesis in
tryptophan metabolism pathway (Figure 1). The enzyme also catalyzes the conversion
of 5-hydroxy-indoleacetate to 5-methoxy-indoleacetate (a second reaction in
© 2013 Azam and Abbasi; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Azam and Abbasi Theoretical Biology and Medical Modelling 2013, 10:63
http://www.tbiomed.com/content/10/1/63tryptophan metabolism) [1]. ASMT lies under three critically important sub-classes of
enzyme, transferases, one-carbon group transferases, and methyltransferases. ASMT
protein is found in both prokaryotes and eukaryotes. In humans, ASMT gene encoded
this enzyme. There are two identical copies of ASMT (one on the X arm and another
on the Y arm of chromosome) [2,3]. High Expression of ASMT gene is evident in pineal
parenchymal tumors (PPTs). The presence of abnormally high levels of ASMT in pineal
gland could serve as an indication of the existence of PPTs in the brain [4]. Different
levels of melatonin are used as a trait marker for prescribing the mood disorders e.g.
seasonal affective disorder, bipolar disorder, or major depressive disorder. In addition,
melatonin levels can also be used to calculate the severity of a patient’s illness at a given
point in time. As studies have revealed a direct correlation between the amount of
ASMT in the pineal gland and the melatonin level, additional knowledge of ASMT
could provide valuable insight into the nature and onset of these impairing disorders
[5]. In studying the various properties associated with protein-ligand interactions, dock-
ing is a powerful tool. Since molecules in nature have a tendency to be found in their
lowest energy form, the final configuration should also be of low energy [6]. Under-
standing these properties is crucial in the rational design of potent inhibitors.
Molecular Docking is an effective and competent tool for in silico screening. It is playing
an important and ever increasing role in rational drug design [7,8]. Docking is a computa-
tional procedure of searching for an appropriate ligand that fits both energetically and
geometrically the protein’s binding site. In other words, it is a study of how two or more
molecules e.g. ligand and protein, fit together. The problem is like solving a 3D puzzle [9].
During the past decade, for understanding the formation of intermolecular complexes, the
application of computational methods in this arena has been subjected to intensive re-
search. It is commonly known that molecular binding of one molecule (the ligand) to the
pocket of another molecule (the receptor), which is commonly a protein, is responsible
for accurate drug activity. Molecular docking has been proved very efficient tool for novel
drug discovery for targeting protein. Among different types of docking, protein-ligand
docking is of special interest, because of its application in medicine industry [10]. Protein-
ligand docking refers to search for the accurate ligand conformations within a targeted
protein when the structure of proteins is known [11].
Docking procedures are basically the combination of search algorithms and scoring
function. The largest number of search algorithms and scoring functions are available.
Search algorithms predict the ligand binding orientation and conformations commonly
referred to as posing [11]. Some common search algorithms are [9]: Monte Carlo
methods, Genetic algorithms, Fragment-based methods, Point complementary
methods, Distance geometry methods, Tabu searcher and Systematic searches. In order
to differentiate between the active and random compounds, the scoring functions are
employed. The scoring functions predict binding free energies in ligand-protein
Figure 1 ASMT catalyzed melatonin synthesis.
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http://www.tbiomed.com/content/10/1/63docking generally in 7–10 kJ/mol [12]. Numbers of molecular docking software are
employed in drug research industry [9]. The most popular and commonly used soft-
wares for molecular docking are AutoDock [13-15], AutoDock/Vina [16], GOLD
[17,18], FlexX [19], FRED [20], DOCK [21] and ICM [22]. For docking purpose, Auto-
Dock/Vina employed Broyden-Fletcher-Goldfarb-Shanno algorithm and it significantly
improves the average accuracy of the binding mode predictions compared to AutoDock
4 [16]. FlexX employed an IC algorithm. IC algorithm attempts to reconstruct the
bound ligand by first placing a rigid anchor in the binding site and later using a greedy
algorithm to add fragments and complete the ligand structure. GOLD considers the de-
gree of freedom in the binding site that corresponds to reorientation of hydrogen bond
donor and acceptor groups. This degree of freedom represents only a very small frac-
tion of the total conformational space that is available but should account for a signifi-
cant difference in binding energy values [23].
In connection with efforts rendered in searching for novel inhibitors of ASMT, we per-
form a comparative docking study with four extensively used programs: AutoDock/Vina,
GOLD, FlexX and FRED. The docking accuracy and scoring reliability of the selected
docking approaches were evaluated by docking seventy three melatoninergic ligands with
ASMTand correlating the predicted binding affinities with the experimental values.
Methods
ASMT and melatoninergic inhibitors
The protein used in the docking study was obtained through homology modeling by
Azam et al., [24]. Dogsite web server was employed to detect the binding pocket of
ASMT (Table 1) [25]. Seventy three structurally diverse ASMT inhibitors (Additional
file 1) with representative good biological activity were selected from the literature
[26-31]. The 2D structures of the melatoninergic inhibitors were drawn using chemical
Table 1 Active site residues of ASMT
Amino acids One letter code
TRP 11, 117, 285 W
LYS 107, 223 K
TYR 108 131, 336 Y
GLY 110, 263 G
SER 113 S
CYS 116 C
THR 112, 144, 207, 336 T
LEU 142, 186, 308, 326 L
GLU 152 E
PHE 26,143, 156, 237 F
ILE 277, 310 I
ASP 238, 268, 284 D
ARG 210, 280 R
ASN 330 N
VAL 333 V
GLN 253, 334 Q
MET331 M
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http://www.tbiomed.com/content/10/1/63structure drawing package, ChemOffice 2004 [32]. The conformational energies of in-
hibitors were minimized by using UCSF Chimera [33]. The minimized structures were
then subjected to docking studies.
Docking protocol
Molecular docking protocols are widely used for predicting the binding affinities for a
number of ligands. In current work, our aim was to examine the possibility of an exist-
ing relationship between the experimental bioactivities of the inhibitors under study
and the docking scores. In order to get accurate results, all the docking experiments
were performed with the default parameters. The time to dock one ligand was approxi-
mately 1–2 min. Docking with AutoDock/Vina, GOLD and FRED was performed on a
Linux workstation (openSUSE11.4) with an Intel Pentium D processor (3.0 GHz) and
1 GB of RAM where as FlexX was run on windows 7 equipped with an Intel® Atom™
processor (1.67 GHz) and 1GB of RAM.
Docking using AutoDock/Vina
Intermediary steps, such as pdbqt files for protein and ligands preparation and grid box
creation were completed using Graphical User Interface program AutoDock Tools
(ADT). ADT assigned polar hydrogens, united atom Kollman charges, solvation param-
eters and fragmental volumes to the protein. AutoDock saved the prepared file in
PDBQT format. AutoGrid was used for the preparation of the grid map using a grid
box. The grid size was set to 60 ×60 ×60 xyz points with grid spacing of 0.375 Å and
grid center was designated at dimensions (x, y, and z): -1.095, -1.554 and 3.894. A scor-
ing grid is calculated from the ligand structure to minimize the computation time.
AutoDock/Vina was employed for docking using protein and ligand information along
with grid box properties in the configuration file. AutoDock/Vina employs iterated
local search global optimizer [34,35]. During the docking procedure, both the protein
and ligands are considered as rigid. The results less than 1.0 Å in positional root-mean-
square deviation (RMSD) was clustered together and represented by the result with the
most favorable free energy of binding. The pose with lowest energy of binding or bind-
ing affinity was extracted and aligned with receptor structure for further analysis.
Docking using GOLD (Genetic Optimization for Ligand Docking)
GOLD utilizes genetic algorithm to explore the rotational flexibility of receptor hydro-
gens and ligand conformational flexibility [18]. In GOLD docking was carried out using
the wizard with default parameters population size (100); selection- pressure (1.1);
number of operations (10,000); number of islands (1); niche size (2); and operator
weights for migrate (0), mutate (100), and crossover (100) were applied. The active site
with a 10 Å radius sphere was defined by selecting an active site residue of protein. De-
fault Genetic Algorithm settings were used for all calculations and a set of 10 solutions
were saved for each ligand. GOLD was used by a GoldScore fitness function. GoldScore
is a molecular mechanism like function and has been optimized for the calculation of
binding positions of ligand. It takes into account four terms:
Fitness ¼ S hbext ðÞ þ 1:3750   S vdwext ðÞ þ S hbint ðÞ þ 1:0000   S int ðÞ
S int ðÞ ¼ S vdwint ðÞ þ S tors ðÞ
ð1Þ
Where Shb_ext is the protein-ligand hydrogen bonding and Svdw_ext are the van der
waals interactions between protein and ligand. Shb_int are the intramolecular
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strain in the ligand.
Docking using FlexX
FlexX (which is now a part of LeadIT) is a flexible docking method that uses an Incre-
mental Construction (IC) algorithm and a pure empirical scoring function similar to
the one developed by Böhm and coworkers [36] to place ligands into the active site. IC
algorithms first dissect each molecule into a set of rigid fragments according to rotat-
able bonds, and then incrementally assemble the fragments around the binding pocket
[19]. For docking studies, the pdb files of ligands were transformed into a SYBYL mol2
file format and a ligands library was generated. A receptor description file was prepared
through the FlexX graphic interface. An active site was defined by selecting the residue
of the protein. The active site includes protein residues around 10 Å radius sphere cen-
tered on the center of mass of the ligand. Based on energy values, top ten ranked poses
for each ligand in data set were selected for further analysis.
The free binding energy ΔG of the protein–ligand complex is given by:
ΔG ¼ΔG0 þ ΔGrotxNrot
þ ΔGhb ∑
neutralHbonds
f ΔR;Δα ðÞ
þΔGioΣionicint: f ΔR;Δα ðÞ
þΔGarΣaroint:f ΔR;Δα ðÞ
þΔGlipoΣlipocont:f   ΔR ðÞ
ð2Þ
Here, f (ΔR, Δα) is a scaling function penalizing deviations from the ideal geometry
and Nrot is the number of free rotatable bonds that are immobilized in the complex.
The terms ΔGhb, ΔGio, ΔGar and ΔG0 are adjustable parameters. ΔGlipo is lipophilic
contact energy (Rarey et al., [19]).
Docking with FRED (Fast Rigid Exhaustive Docking)
FRED uses multi-conformer docking algorithm which separately generates a set of low-
energy conformers, and then do rigid docking for each conformer [37]. In order to
carry out correct docking, FRED required accurately prepared receptor file as well as a
ligand conformer library. The receptor file was prepared by using make-receptor file
provided in FRED whereas ligand conformer library was created in Omega 2.3.2 (Open-
Eye Scientific Software) with default settings. The volume of the docking box centered
on the receptor was expanded in all directions until it was approximately 31671 Å
3.
The dimensions of the box were: 28.10 Å × 32.91 Å × 34.25 Å. FRED with a Gaussian
type fitting scoring function Chemgauss4 was used to dock ASMT with ligands con-
former library in order to obtain a potent inhibitor against ASMT. Chemgauss4 uses
the potentials between the chemically matched positions around the ligand docked
pose. Those chemical positions are complementary to the nearby specific groups in the
receptor. Generally, the interactions are either hydrogen bond donors or acceptors and
a favorable hydrogen bond score is obtained when a polar hydrogen position on one
molecule overlaps a lone pair position on another molecule. The interactions which
can be scored by Chemgauss functions are: steric, acceptor, donors, coordinating
groups, metals, lone pairs, polar hydrogens and chelator coordinating groups [38].
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In order to recognize an accurate docking routine for carrying out molecular docking
studies of ASMT protein as well as to identify the potent inhibitors against that protein,
four widely used docking routines (AutoDock/Vina, GOLD, FlexX and FRED) are com-
pared in this work. Each docking routine returned top ten ranked docked poses for
each ligand. The number and categories in which the dock poses fall are summarized
in Table 2. Among all the studied docking routines, AutoDock/Vina was found to be
the best for carrying out blind docking and in generating poses that bind best deep in-
side the 5 Å of the binding pocket. It generated 70% good poses. Gold and FRED also
performed well with 65% and 45% of good poses respectively. FlexX returned no signifi-
cant results in generating accurate poses. This variation might be because of the algo-
rithms employed by the routines, grid box specification and active site residue
specification. Overall results showed relatively poor performance ranging from 41 to
70%. These percentages were surprisingly low, indicating the docking programs often
failed to find the correct binding mode. The percentages of docked poses for ASMT
melatoninergic inhibitors docked complexes obtained by the different docking routines
are shown in Figure 2.
Evaluation of docking accuracy of docking programs requires the programs run at ap-
proximately comparable speeds. The average time required for carrying out the docking
calculation using different scoring functions and docking routines of a single ligand is
shown in Table 3. According to Table 3 in the context of the average time required for
docking a single ligand, FRED is the fastest algorithm with average 1.4 sec, followed by
Gold and AutoDock/Vina with an average time of 1.66 and 2–3 sec respectively. FlexX
seemed to be the more time-consuming approach.
Table 2 Number of good, fair and poor ASMT docked complexes obtained by the
different docking routines
Pose AutoDock/Vina GOLD FlexX FRED
Good
a 43 35 18 25
Fair
b 18 22 28 13
Poor
c 12 16 22 15
agood on the bases of lowest binding affinities, RMSD < 2 Å and high docked scores.
bfair pose on the bases of lowest to moderate binding affinities, RMSD < 3 Å and >2 Å and moderate docking scores.
cpoor on the bases of high binding affinities, greater RMSD and lowest docked scores.
Figure 2 Percentages of docked poses for ASMT docked complexes obtained by the different
docking routines.
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and the calculated scores generated by each docking routine for ASMT docked com-
plexes are shown in Figure 3. The best squared correlation coefficient of r
2 =0 . 6 6
was observed between binding affinities (AutoDock/Vina) and experimental values
(Figure 3a). Low values of correlation for the Gold scores (r
2 =0.37) and FlexX scores
(r
2 =0. 28) was obtained. FRED (Chemgauss4), due to its rigid-body approach, pre-
sented the lowest value of the squared correlation coefficient among the tested rou-
tines (Figure 3d).
The 2D view of protein–ligand interactions of the best poses generated by all the four
studied routines are shown in Figure 4. As clearly depicted in Figure all molecules ex-
hibit the same binding mode. Interestingly, important interactions can be found be-
tween these atoms and the residues Ser213, Ser98, Val97, Thr100, Val211, Ser227,
Arg210, Arg280, Phe212, Leu198, Ile198, Ser104, Thr195, Leu160, Tyr327, Tyr108,
Trp117, Leu326, Phe29, Phe19, Gln334, Asn330, Ala159, Lys107, Met105 which dir-
ectly participate in the catalytic mechanism of this enzyme. The ligand–enzyme com-
plex is stabilized mainly by hydrogen bonds and hydrophobic interactions. All the top
docked poses generated by each docking routine exhibited well-established bonds with
Table 3 Time required for the docking of a single ligand
Docking routine Docking time
AutoDock/Vina 2-3 sec
GOLD 1.66 sec
FlexX 5 sec
FRED 1.4 sec
Figure 3 Plot showing the correlation between the experimental bioactivities (PIC50) and a) binding
affinities b) GOLD scores c) Chemgauss4 scores and d) binding energies.
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lowest docked binding affinities and high docking scores are generally used as a stand-
ard selection in most of the docking programs. The best poses of ASMT-B22 generated
by AutoDock/Vina, Gold and FlexX and ASMT-A3 by FRED are shown in Figure 5.
Figure 4 Docked conformation of ASMT with top ranked ligands showing the interaction with the
crucial residues in the active site cleft using: (a) AutoDock/Vina (b) GOLD (c) FlexX (d) FRED.
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gen bonding, ionic interactions of B22 within ASMT active site are shown in Figure 5a.
Different sets of hydrogen bonding interactions with polar side chain residues of
Arg280, Ser104, Thr100, Tyr108 and with phenol of Tyr327 are observed at distances
within 4 Å. An ionic interaction with the side chain residue of Arg280 is also observed.
The indole ring and other side chain carbons of B22 formed strong hydrophobic inter-
actions with nonpolar residues Leu160, Tyr327, Tyr108, Leu326, Trp117 and Phe26
and are suggested to increase binding affinity (Table 4).
Figure 5b shows the binding mode of top pose B22ASMT complex generated by
GOLD with GoldScore of 64.88. Compound B22 was mediating hydrogen bond interac-
tions with the side chain residues of Arg280, Ala159, Tyr327 and Tyr108. The phenol
and indole ring of B22 formed favorable hydrophobic contacts with Tyr108, Tyr327,
Tyr366, Trp117 and Leu326 and ionic interaction with Arg280.
The FlexX generated 10 solutions for B22. The highest-ranking solution has a binding
energy of −25.45 kJ/mol. Hydrogen bonds with a backbone and side chain residues of
Arg210, Lys223 and Thr207, back bone residues of Val211, back bone residues of
Phe212 and Glu224 are observed. The strong hydrophobic interactions were with
Thr195, Lys223, Leu228, Arg169, pyrrole ring of His209, Val211 and aromatic ring of
Phe212. Ionic interactions were with Arg210 and Glu224 (Figure 5c).
The top ranked pose of ASMT-A3 generated by FRED has Chemgauss4 score of −9.87.
Phenolic side chain of Tyr327, Tyr108, amide side chain of Asn330 and side chain resi-
dues of Lys107 formed strong hydrogen bonding interactions with electronegative atoms
of ligand. Phenol group of Tyr108, and the aromatic ring of Trp117 and Tyr 327 were
highlighted as major contributor of hydrophobic interactions. A3 also resulted in favor-
able ionic interactions through the active site with the back bone residues of Asn 330 and
Figure 5 Docked poses: Binding mode of top ranked docked poses into ASMT binding cavity:
(a) AutoDock/Vina (b) GOLD (c) FlexX (d) FRED For clarity, only interacting important residues are
displayed in CPK style. The inhibitors were designed in licorice style, and part of the enzyme in the
background was visualized in New Ribbon style using the VMD (Visual Molecular Dynamics) program.
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Compound Hydrogen bonding Ionic interactions Hydrophobic interactions
ASMTB22 (AutoDock/Vina) Arg280:HH11…O 3.67 Å Arg280:NH1…O 3.78 Å Leu160:CD2…C 3.69 Å
Arg280:HH12…O 3.29 Å Tyr327:CE1…C 3.40 Å
Arg280:HH12…O 3.85 Å Tyr108:CZ…C 3.97 Å
Ser104:HG…N 3.83 Å Tyr108:CE2…C 3.64 Å
Thr100:HG1…O 2.23 Å Tyr108:CE2…C 3.77 Å
Thr100:HG1…O 3.58 Å Tyr108:CE2…C 3.87 Å
Tyr108:HH…N 3.56 Å Tyr108:CD2…C 3.92 Å
Tyr327: HH…O 3.84 Å Tyr108:CD2…C 3.97 Å
Leu326:CD2…C 3.49 Å
Leu326:CB…C 3.65 Å
Leu326:CB…C 3.78 Å
Leu326:CG…C 3.98 Å
Leu326:CD2…C 3.49 Å
Leu326:C…C 3.89 Å
Trp117:CD1…C 3.90 Å
Trp117:CE2…C 3.58 Å
Trp117:CZ2…C 3.96 Å
Trp117:CD2…C 3.62 Å
Trp117:CD2…C 3.94 Å
Trp117:CG…C 3.72 Å
Trp117:CD2…C 3.73 Å
Phe26:CZ…C 3.42 Å
Phe:26:CE2…C 3.81 Å
GOLD Arg280:HH12…O 2.30 Å Arg280:NH1…O 2.91 Å Tyr108: CE1…C 3.45 Å
Arg280:HH11…O 2.89 Å Tyr108: CE1…C 3.96 Å
Arg280:HH11…O 3.91 Å Tyr108:CE1…C 3.92 Å
Asn330:H…N 3.95Å Tyr108: CZ…C 3.43 Å
Ala159:O…H 2.67Å Tyr108: CD2…C 3.86 Å
Tyr327:HH…O 3.88 Å Tyr108:CD2…C 3.78 Å
Tyr108:HH…N 3.90 Å Tyr108:CE2…C 3.77 Å
Tyr108:HH…N 3.48 Å Tyr108:CZ…C 3.91 Å
Tyr108:OH…H 3.71 Å Tyr108:CZ…C 3.79 Å
Ala159:O…H 2.67Å Tyr108:CD2…C 3.87 Å
Tyr108:HH…N 2.80 Å Tyr327:CD1…C 3.76 Å
Trp117:HE1…O 3.89 Å Tyr327:CD1…C 3.74 Å
Tyr327:CD1…C 3.58 Å
Tyr327:CB…C 3.82 Å
Tyr366:CE2…C 3.86 Å
Tyr366:CE2…C 3.89 Å
Trp117:CG…C 3.57 Å
Trp117:CE2…C 3.98 Å
Trp117:CZ2…C 3.51 Å
Trp117:CH2…C 3.48 Å
Trp117:CB2…C 3.98 Å
Asn330:CB…C 3.53 Å
Leu326:C…C 3.55 Å
Leu326:CB…C 3.99 Å
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(Continued)
FlexX Arg210:H…O 2.22Å Arg210:N…O 3.17Å Thr195:CB…C 3.07 Å
Arg210:H…N 3.32Å Arg210:NH1…O 3.34 Å Thr195:CG2…C 3.54 Å
Arg210:HH11…N 3.29 Å Lys223:NZ…O 2.68 Å Lys223:CE…C 3.39 Å
Arg210:HH12…O 2.69 Å Glu224:OE2…N 2.96 Å Lys223:CE…C 3.99 Å
Arg210:HH11…O 3.26 Å Glu224:OE1…N 3.32 Å Leu228:CD2…C 3.14 Å
Lys223:HZ3…O 2.34 Å Leu228:CD2…C 3.51 Å
Lys223:HZ1…O 2.51 Å Leu228:CD1…C 3.95 Å
Lys223:HZ2…O 3.73 Å Arg169:CG…C 3.55 Å
Thr207:HG1…O 1.65 Å Arg169:CB…C 3.83 Å
Thr207:HG1…O 3.41 Å His209:CD2…C 2.63 Å
Val211:O…H 1.67 Å His209:CD2…C 3.31 Å
Val211:N…H 3.85 Å His209:CD2…C 3.39 Å
Phe212:N…H 2.98Å His209:CG…C 3.50 Å
Glu224:OE2…H 1.97 Å His209:CG…C 3.84 Å
Glu224:OE1…H 2.54 Å His209:CA…C 3.35 Å
His209:CA…C 3.92 Å
S His209:CB…C 3.93 Å
Val211:CA…C 3.49 Å
Val211:CA…C 3.51 Å
Val211:C…C 3.04Å
Val211:C…C 3.61Å
Arg210:C…C 3.94 Å
Arg210:C…C 3.96 Å
Phe212:CB…C 3.65 Å
Phe212:CB…C 3.62 Å
Phe212:CD2…C 3.66 Å
Phe212:CD2…C 3.38 Å
Thr195:CG2…C 3.54 Å
Thr195:CB…C 3.07 Å
ASMT-A3 FRED Tyr108:HH…N 3.14 Å Asn330:ND2…O 3.25 Å Tyr327:CD1…C 3.88 Å
Tyr108:HH…O 3.37 Å Lys107:NZ…O 2.84 Å Tyr327:CD1…C 3.84 Å
Asn330:HD21…O 3.75 Å Tyr327:CD1…C 3.61 Å
Asn330:HD22…O 3.33 Å Tyr327:CD1…C 3.90 Å
Lys107:HZ3…O 1.85 Å Tyr327:CE1…C 3.87 Å
Lys107:HZ2…N 3.48 Å Tyr327:CE1…C 3.80 Å
Lys107:HZ3…N 3.09 Å Tyr327:CE1…C 3.51 Å
Lys107:HZ2…O 3.21 Å Tyr327:CD1…C 3.59 Å
Lys107:HZ1…O 3.25 Å Tyr327:CE1…C 3.68 Å
Tyr327:HH…N 3.90 Å Tyr108:CZ…C 3.93 Å
Tyr108:CE2…C 3.35 Å
Tyr108:CE2…C 3.76 Å
Tyr108:CE2…C 3.90 Å
Tyr108:CD2…C 3.73 Å
Tyr108:CZ…C 3.86 Å
Trp117:CE2…C 3.69 Å
Trp117:CZ2…C 3.34 Å
Trp117:CD1…C 3.73 Å
Trp117:CH2…C 3.45 Å
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gold scores and binding energies
S. # Ligand PIC50 Chemgauss4
score
Binding affinities
(kcal/mol)
GOLD
scores
Binding energies
(kJ/mol)
1 A3 Fred Best 7.54 −9.873667 −9 59.09 −18.82
2 7e 7.17 −9.772967 −7.7 58.27 −20.66
3 B20 7.17 −9.772967 −7.7 58.31 −23.75
4 A7 7.21 −9.606176 −4.3 55.01 −20.91
5 A19 7.28 −9.497549 −5 55.39 ND
6 6e 7.27 −9.448377 −7.4 56.43 −18.29
7 A2 7.21 −9.376864 −4.3 54.47 −21.03
8 6b 7.18 −9.190106 −7.7 61.41 −18.23
9 B23 7.6 −9.114123 −4.8 42.07 ND
10 10f 4.95 −9.08652 −7.7 56 −17.21
11 B22ADV,Fl.G.Best 7.17 −8.99517 −9.2 64.88 −25.45
12 A6 8.11 −8.828648 −7.7 53.85 −17.84
13 6a 7.85 −8.7937 −7.2 55.17 −20.74
14 A4 7.15 −8.793257 −7.5 39.34 −11.62
15 7a 7.08 −8.77433 −7.2 55.26 −21.36
16 11 l 4.92 −8.765322 −4.9 46.14 −22.29
17 11j 4.17 −8.731167 −4.4 43.8 −18.52
18 11o 4.01 −8.722329 −4.4 40.92 −15.44
19 11 h 4.48 −8.703998 −4.7 44.39 −17.31
20 21 8.73 −8.70327 −8.4 57.6 −22
21 10b 4.63 −8.558372 −7.8 59.67 −23.03
22 11 k 4.37 −8.527354 −4.5 40.02 −18.04
23 A16 7.43 −8.509283 −7.5 59.91 −17.63
24 A17 7.37 −8.497904 −7.2 47.57 ND
25 A14 7.74 −8.497536 −7.1 51.87 −16.17
26 B27 7.85 −8.416398 −7.3 56.36 −17.62
27 10a 4.79 −8.404483 −7.4 56 −17.51
28 11i 4.28 −8.376978 −5.4 44.83 −18.15
29 B25 7.25 −8.366087 −8.7 58.6 −21.6
30 10e 4.25 −8.366087 −8.7 60 −21.8
31 11 t 5.04 −8.309559 −4.5 40 ND
32 11p 4.56 −8.237691 −5.8 39.37 −11.19
33 18 7.83 −8.195755 −6.9 51.11 −19.33
34 11f 4.72 −8.194806 −4.7 44.48 ND
35 dbc-amp 5.67 −8.177967 −8.4 64.44 −19.67
36 11r 4.23 −8.096362 −4.5 48.35 −15.37
37 11 g 4.73 −8.094617 −4.8 44.78 −18.91
38 A5 7.55 −8.016981 −7.6 50.77 −14.78
39 11n 5.04 −8.002397 −5.1 53.35 −11.13
40 11 m NA −8.002397 −6.7 49.27 −11.13
41 11b 4.49 −7.910209 −5 41.77 −18.51
42 B28 7.8 −7.861473 −7.2 59.97 −24.45
43 11c 4.06 −7.86083 −4.5 46.85 −17.83
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http://www.tbiomed.com/content/10/1/63side chain residues of Lys107 (Figure 5d) (Table 4). The lowest binding affinity, high Gold-
Score, a low binding energy and number of observed hydrogen bonding interactions be-
tween the backbone residues and the various important residues at the entrance of the
pocket enables B22 to be a strongly binding inhibitor of ASMT.
As shown in Table 5, among the provided data set AutoDock/Vina docked all the seventy
three inhibitors with binding affinities in a convincing range. Like AutoDock/Vina, GOLD
also docked all the provided inhibitors however GOLD tends to be limited in terms of lig-
and flexibility. Kellenberger reported that out of 100 protein-ligand complexes, GOLD suc-
cessfully docked 80% of the ligands at an RMSD value of 2.0 Å [37]. Likewise Perole [39]
while doing virtual screening of HIV-1 protease established that when looking at only the
top 10% of the rankings, GOLD will accurately bind 60% of the ligands. Additionally GOLD
Table 5 Comparison: showing the PIC50 values, chemgauss scores, binding affinities,
gold scores and binding energies (Continued)
44 11q 6.39 −7.821584 −4.7 48.09 −16.1
45 17 7.91 −7.810211 −6.6 63.09 −18.35
46 B24 7.96 −7.760382 −7.9 62.43 −19.28
47 8a 4.92 −7.682957 −7.5 55.05 −17.4
48 11 s 4.98 −7.644275 −5.3 42.3 −16.93
49 A11 7.49 −7.604273 −8.6 62 −23.45
50 A15 7.68 −7.576113 −7.5 61.77 −17.13
51 B26 7.19 −7.290902 −7.7 50.41 −18.17
52 A13 8.04 −7.28357 −5 60.21 −14.29
53 A1 7.36 −6.714446 −7 50.72 −15.67
54 20b 6.95 ND −8.8 62.58 −18.29
55 20c 8.09 ND −8.7 63.83 −18.32
56 Ramelotinine 8.5 ND −8.3 45.36 −16.17
57 16 6.5 ND −7.8 60.81 −22.52
58 2a 6 ND −95 6 −19.08
59 4 7.06 ND −7.8 57 −20.4
60 5-Methoxy 3.82 ND −6.7 45.51 −20.56
61 11 2.68 ND −8.2 51.08 −16.31
62 12c 7.93 ND −7.8 55.42 −23.75
63 20a 6 ND −7.9 59.03 −24.08
64 A9 7.27 ND −4.3 43.31 −22.65
65 A10 7.96 ND −4 54.87 −19.04
66 19 5.12 ND −7.1 51.87 −16.06
67 20 6.23 ND −8.3 57.53 −22.06
68 Melotinine 6.79 ND −7.1 50.47 −17.51
69 N-Acetyl 5.15 ND −7.2 44.88 −19.38
70 Agomalotinine 8.67 ND −4.9 49.75 −14.74
71 SAM 8.04 ND −6 45.21 −17.46
72 A8 7.85 ND −6.8 50.18 −15.06
73 A12 7.29 ND −7.1 37.66 ND
Highlighted ones are the best docking hits according to the corresponding affinities and scores.
ND: Not Docked.
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tions plays an important role in binding [39].
The performance of FRED with respect to ranking the inhibitors in the list was poor.
FRED ranked inhibitor B22 on the 11
th place whereas all the remaining routines ranked
B22 in 1
st place. FRED docked fifty three inhibitors out of seventy three provided inhib-
itors which is a low number as compared to other routines. Kellenberger et al., con-
cluded in their work that FRED had problems with small, polar and buried ligands [37].
FlexX docked sixty eight inhibitors out of seventy three. The most severe restriction of
FlexX is that it treats receptor as a rigid entity. Leach in 1994 reported an approach
handling receptor flexibility [40].
In the light of the above analysis, the B22ASMT docked pose generated by Auto-
Dock/Vina produced the best results. It forms hydrogen bonds, hydrophobic and ionic
interactions with the important residues of the binding pocket of ASMT thus stabiliz-
ing the structure of target receptor. The dock pose with least binding energy has the
highest affinity and hence is the best docked conformation.
Conclusion
Docking and scoring have evolved significantly over the past years. It has become a
valuable tool in drug discovery process. Our goal of this study was to explore the feasi-
bility of four different docking approaches: (AutoDock/Vina, GOLD, FRED and FlexX)
for our target ASMT and to find out the lead compound. We compared the predictive
power of each docking and scoring function. Our results suggest that all docking pro-
grams studied here do a reasonable job in docking and should aid significantly the drug
discovery process. However, AutoDock/Vina consistently outperformed as compared to
other programs and was found to be relatively more useful in blind docking pose pre-
diction. Moreover, analysis of the docked ligands with the protein brought into focus
some important interactions operating at the molecular level. The results of the ligand
docking showed that the binding pocket involves the amino acid residues Ser213,
Ser98, Val97, Thr100, Val211, Ser227, Arg210, Arg280, Phe212, Leu198, Ile198, Ser104,
Thr195, Leu160, Tyr327, Tyr108, Trp117, Leu326, Phe29, Phe19, Gln334, Asn330,
Ala159, Lys107, Met105. The important hydrogen bond forming amino acid residues
was Arg280, Thr100, Tyr108, Asn330, Trp117 and Tyr327. In conclusion we have dis-
covered a highly potent lead compound which will be useful for the design of novel less
toxic and highly efficient drug for the treatment of bipolar disorders and PPTs.
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